<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03548623</url>
  </required_header>
  <id_info>
    <org_study_id>CRC2017PPiB</org_study_id>
    <nct_id>NCT03548623</nct_id>
  </id_info>
  <brief_title>Patient Preference in Blood Pressure Therapy</brief_title>
  <official_title>Patient Preference in Blood Pressure Therapy: Questioning of Patients With Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roland E. Schmieder</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institute for Preventive Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Written surveys of patients with high blood pressure are designed to determine how they would
      likely decide if, in addition to taking medication, they had another option to treat their
      hypertension.

      The alternative treatment option is renal sympathetic denervation using catheter ablation.
      This new treatment method is not yet used in the standard care. Currently, studies are being
      conducted in specific centers to demonstrate the efficacy of this treatment.

      Questionnaires are used to determine the preference of patients for one or the other option
      of hypertension treatment. So far, there are no findings.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">October 31, 2018</completion_date>
  <primary_completion_date type="Actual">April 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Preference of treatment</measure>
    <time_frame>3 months</time_frame>
    <description>Questionnaires</description>
  </primary_outcome>
  <enrollment type="Actual">1000</enrollment>
  <condition>Arterial Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  male and female

          -  &gt; 18 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  untreated Hypertension

          -  treated Hypertension with one or more medications

        Exclusion Criteria:

          -  illiteracy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute for Preventive Medicine</name>
      <address>
        <city>Nuremberg</city>
        <zip>90471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>April 23, 2018</study_first_submitted>
  <study_first_submitted_qc>June 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2018</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-Nürnberg Medical School</investigator_affiliation>
    <investigator_full_name>Roland E. Schmieder</investigator_full_name>
    <investigator_title>Full Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>renal denervation</keyword>
  <keyword>preference</keyword>
  <keyword>shared decision making</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

